Isolation of plasma membrane fragments from cultured murine melanoma cells.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1983-06-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-291X(83)91749-7PMID 6870870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of plasminogen activator secretion, interferon induction and proliferation in murine macrophages

  1983cited by this paper
• Ca2+-free perfusion of rat heart reveals a (Na+ + K+) ATPase form highly sensitive to ouabain

  1982cited by this paper
• Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.

  1981cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.

  1980cited by this paper
• Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells.

  1980cited by this paper
• Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments.

  1980cited by this paper
• Shedding from the cell surface of normal and cancer cells.

  1980cited by this paper
• Antigen shedding by human breast-cancer cells in vitro and in vivo.

  1978cited by this paper
• Spontaneous shedding of plasma membrane fragments by human cells in vivo and in vitro.

  1977cited by this paper
• The cancer cell: dynamic aspects and modification in cell-surface organization (second of two parts).

  1976cited by this paper
• Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity.

  1976cited by this paper
• Studies of 5'-nucleotidase in the perfused rat heart. Including measurements of the enzyme in perfused skeletal muscle and liver.

  1976cited by this paper
• The release of high-molecular-weight alkaline phosphatase and leucine aminopeptidase into the media of cultured human cells.

  1975cited by this paper
• Regan isoenzyme and human chorionic gonadotropin in ovarian cancer.

  1975cited by this paper
• Immunological escape mechanism in spontaneously metastasizing mammary tumors.

  1975cited by this paper
• The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism

  1973cited by this paper
• The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

  1973cited by this paper
• Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

  1962cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma.

  2026cites this paper
• Free flow electrophoresis allows quick and reproducible preparation of extracellular vesicles from conditioned cell culture media

  2022cites this paper
• Scaled preparation of extracellular vesicles from conditioned media.

  2021cites this paper
• Size-Exclusion Chromatography as a Technique for the Investigation of Novel Extracellular Vesicles in Cancer

  2020cites this paper
• The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics

  2019cites this paper
• Targeting Inflammatory Vasculature by Extracellular Vesicles

  2018cites this paper
• Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.

  2017cites this paper
• Isolation of Biologically Active Exosomes from Plasma of Patients with Cancer.

  2017cites this paper
• Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.

  2017cites this paper
• Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey

  2016cites this paper
• Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer

  2016cites this paper
• Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array

  2016cites this paper
• Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression

  2016cites this paper
• Tumor-Derived Exosomes and Their Role in Cancer Progression.

  2016cites this paper
• Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array

  2016cites this paper
• UvA-DARE ( Digital Academic Repository ) Detection of extracellular vesicles : size does matter

  2015cites this paper
• Biological Impact of Membranous Nanostructures

  2015cites this paper
• Ready-made chromatography columns for extracellular vesicle isolation from plasma

  2015cites this paper
• Towards traceable size determination of extracellular vesicles

  2014cites this paper
• Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.

  2014cites this paper
• The emerging role of extracellular vesicles as biomarkers for urogenital cancers

  2014cites this paper
• Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes

  2014cites this paper
• Single-step isolation of extracellular vesicles by size-exclusion chromatography

  2014cites this paper
• Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.

  2012cites this paper
• Stability of membranous nanostructures: a possible key mechanism in cancer progression

  2012cites this paper
• The Interface of Metastatic Tumours and the Immune System

  2012cites this paper
• Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process

  2011cites this paper
• Suppression of membrane microvesiculation--a possible anticoagulant and anti-tumor progression effect of heparin.

  2009cites this paper
• Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner.

  2009cites this paper
• Cells on Membrane Vesicles Shed by 8701-BC Breast Carcinoma Integrins , and Human Lymphocyte Antigen Class I Molecules 1 β Selective Localization of Matrix Metalloproteinase 9 , Updated

  2006cites this paper
• BIOCHEMICAL AND NMR STUDIES ON STRUCTURE AND RELEASE ADENOCARCINOMA CELLS CONDITIONS OF RNA-CONTAINING VESICLES SHED BY HUMAN COLON

  2006cites this paper
• Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

  2006cites this paper
• Tumor immune escape mechanisms: impact of the neuroendocrine system

  2006cites this paper
• Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?

  2005cites this paper
• Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.

  2005influential citation
• Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

  2005cites this paper
• Untersuchungen zur ADAM10-vermittelten Spaltung von L1 in Ovarialkarzinomzellen

  2004cites this paper
• Shed membrane vesicles and clustering of membrane-bound proteolytic enzymes.

  2003cites this paper
• m-Calpain Colocalizes with the Calcium-sensing Receptor (CaR) in Caveolae in Parathyroid Cells and Participates in Degradation of the CaR*

  2003cites this paper
• T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.

  2003cites this paper
• Shed membrane fragment-associated markers for endometrial and ovarian cancers.

  2002cites this paper
• Intercellular Transfer of the Cellular Prion Protein*

  2002cites this paper
• Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis.

  2002cites this paper
• Shed Membrane Fragment-Associated Markers for Endometrial and Ovarian Cancers

  2002cites this paper
• Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.

  2001cites this paper
• Membrane vesicles in ovarian cancer fluids: a new potential marker.

  1999cites this paper
• Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.

  1998cites this paper
• Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review).

  1998cites this paper
• Modulation of vesicle shedding in 8701 BC human breast carcinoma cells.

  1998cites this paper
• Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells*

  1997cites this paper
• Expression and Shedding of CD44 Variant Isoforms in Patients With Gynecologic Malignancies

  1996cites this paper
• Expression and shedding of CD44 variant isoforms in patients with gynecologic malignancies.

  1996cites this paper
• Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities.

  1994cites this paper
• Lymphokine-activated killer cell suppressor factor in malignant effusions.

  1991cites this paper
• Effect of retinoic acid on tumor-mediated immunologic alterations in mice bearing a variant of the B16 melanoma.

  1990cites this paper
• Effect of retinoic acid on tumor‐mediated immunologic alterations in mice bearing a variant of the ß16 melanoma

  1990cites this paper
• Alterations of cellular characteristics of a human ovarian teratocarcinoma cell line after in vitro treatment with retinoids.

  1990cites this paper
• Biochemical and NMR studies on structure and release conditions of RNA‐containing vesicles shed by human colon adenocarcinoma cells

  1989cites this paper
• Characterization of plasma membrane shedding from murine melanoma cells

  1988cites this paper
• Analysis of the cell membrane proteolytic enzymes of the B16, F1, F10, and BL6 melanoma and their role in target cell destruction.

  1986cites this paper
• Role of proteases in red blood cell target cell destruction by cells transformed by Rous sarcoma virus mutants.

  1986cites this paper
• Shedding of plasma membrane fragments. Neoplastic and developmental importance.

  1986cites this paper
• SHED MEMBRANE VESICLES: A MECHANISM FOR TUMOR-INDUCED IMMUNOSUPPRESSION

  1985cites this paper
• Inhibition of macrophage Ia antigen expression by shed plasma membrane vesicles from metastatic murine melanoma lines.

  1985cites this paper
• Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles.

  1985cites this paper
• Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages.

  1985cites this paper